These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18288441)

  • 1. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia.
    Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
    Acta Neurochir (Wien); 2008 Mar; 150(3):265-71. PubMed ID: 18288441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260.
    Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
    Prog Brain Res; 2008; 170():519-25. PubMed ID: 18655905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage.
    László FA; Varga C; Nakamura S
    Eur J Pharmacol; 1999 Jan; 364(2-3):115-22. PubMed ID: 9932713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological half-life and organ distribution of [3H]8-arginine vasopressin following administration of vasopressin receptor antagonist OPC-31260.
    Molnár AH; Varga C; Janáky T; Tóth G; Tóth G; Farkas J; László F; László FA
    Regul Pept; 2007 Jun; 141(1-3):12-8. PubMed ID: 17258819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats.
    Yamamura Y; Nakamura S; Itoh S; Hirano T; Onogawa T; Yamashita T; Yamada Y; Tsujimae K; Aoyama M; Kotosai K; Ogawa H; Yamashita H; Kondo K; Tominaga M; Tsujimoto G; Mori T
    J Pharmacol Exp Ther; 1998 Dec; 287(3):860-7. PubMed ID: 9864265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats.
    Nakamura S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Yamamura Y; Mori T; Tominaga M
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1005-11. PubMed ID: 11082435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzamil prevents brain water accumulation in hyponatraemic rats.
    Sulyok E; Pál J; Vajda Z; Steier R; Dóczi T
    Acta Neurochir (Wien); 2009 Sep; 151(9):1121-5. PubMed ID: 19415169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous vasopressin regulates Na-K-ATPase and Na(+)-K(+)-Cl(-) cotransporter rbsc-1 in rat outer medulla.
    Bertuccio CA; Ibarra FR; Toledo JE; Arrizurieta EE; Martin RS
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F265-70. PubMed ID: 11788440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of receptor blockade on metabolism and renal actions of vasopressin in conscious dogs.
    Grove L; Christensen P; Bie P
    Acta Physiol Scand; 1998 May; 163(1):93-101. PubMed ID: 9648627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term oral treatment with selective vasopressin V2 receptor antagonist (OPC-31260) on adriamycin-induced heart failure in rats.
    Takeuchi M; Lee JD; Shimizu H; Ueda T
    Int J Cardiol; 2006 Apr; 108(2):231-6. PubMed ID: 16002161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
    Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted overexpression of endothelin-1 in astrocytes leads to more severe cytotoxic brain edema and higher mortality.
    Yeung PK; Lo AC; Leung JW; Chung SS; Chung SK
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1891-902. PubMed ID: 19707218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course changes of vasopressin-induced enlargement of the rat intrastrial space and the effects of a vasopressin type 2 antagonist.
    Nishimura M; Kakigi A; Takeda T; Okada T; Doi K
    Acta Otolaryngol; 2009 Jul; 129(7):709-15. PubMed ID: 18836965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
    Ohnishi A; Orita Y; Okahara R; Fujihara H; Inoue T; Yamamura Y; Yabuuchi Y; Tanaka T
    J Clin Invest; 1993 Dec; 92(6):2653-9. PubMed ID: 8254021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin in vascular regulation and water homeostasis in the brain.
    Kozniewska E; Romaniuk K
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 8():109-16. PubMed ID: 19258667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
    Kazama I; Arata T; Michimata M; Hatano R; Suzuki M; Miyama N; Sanada S; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
    Nephrol Dial Transplant; 2007 Jan; 22(1):68-76. PubMed ID: 16702208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
    Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
    Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
    Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan.
    Miyazaki T; Ohmoto K; Hirose T; Fujiki H
    J Endocrinol; 2010 Jul; 206(1):105-11. PubMed ID: 20392812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.